3681 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
SinoMab Bioscience Ltd. is a clinical stage biopharmaceutical company, which engages in the research, development, and manufacture of therapeutics for the treatment of immunological diseases, primarily monoclonal antibody-based biologics. The company was founded by Shui On Leung on April 27, 2001, and is headquartered in Hong Kong.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
3681 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company